Nanoparticle-based targeted drug delivery

Ahmed, 2006, Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation, Mol. Pharm., 3, 340, 10.1021/mp050103u

Ashcroft, 2006, Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody, Chem. Commun., 3004, 10.1039/b601717g

Avgoustakis, 2002, PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties, J. Controlled Release, 79, 123, 10.1016/S0168-3659(01)00530-2

Barratt, 2000, Therapeutic applications of colloidal drug carriers, Pharmaceut. Sci. Tech. Today, 3, 163, 10.1016/S1461-5347(00)00255-8

Barrera, 1993, Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine), J. Am. Chem. Soc., 115, 11010, 10.1021/ja00076a077

Beletsi, 1999, Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery, Int. J. Pharm., 182, 187, 10.1016/S0378-5173(99)00058-7

Bhadra, 2002, Pegnology: a review of PEG-ylated systems, Pharmazie, 57, 5

Bisht, 2007, Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy, J. Nanobiotechnology, 5, 3, 10.1186/1477-3155-5-3

Brigger, 2002, Nanoparticles in cancer therapy and diagnosis, Adv. Drug Del. Rev., 54, 631, 10.1016/S0169-409X(02)00044-3

Calvo, 1997, Chitosan and chitosan/ethylene oxide–propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines, Pharm. Res., 14, 1431, 10.1023/A:1012128907225

Chen, 1994, Synthesis of albumin-dextran sulfate microspheres possessing favourable loading and release characteristics for the anticancer drug doxorubicin, J. Controlled Release, 31, 49, 10.1016/0168-3659(94)90250-X

Chen, 2003, Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide, Int. J. Peptide Res. Ther., 10, 621, 10.1007/s10989-004-2433-4

Couvreur, 2002, Nanocapsule technology: a review, Crit. Rev. Ther. Drug Carrier Syst., 19, 99, 10.1615/CritRevTherDrugCarrierSyst.v19.i2.10

Couvreur, 1995, Controlled drug delivery with nanoparticles: current possibilities and future trends, Eur. J. Pharm. Biopharm., 41, 2

Davda, 2002, Characterization of nanoparticle uptake by endothelial cells, Int. J. Pharm., 233, 51, 10.1016/S0378-5173(01)00923-1

Desai, 1997, The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent, Pharm. Res., 14, 1568, 10.1023/A:1012126301290

Dunne, 2000, Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles, Biomaterials, 21, 1659, 10.1016/S0142-9612(00)00040-5

Fisher, 2002, Potential new methods for antiepileptic drug delivery, CNS Drugs, 16, 579, 10.2165/00023210-200216090-00001

Fresta, 1995, Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation, J. Pharm. Sci., 84, 895, 10.1002/jps.2600840721

Govender, 2000, Defining the drug incorporation properties of PLA-PEG nanoparticles, Int. J. Pharm., 199, 95, 10.1016/S0378-5173(00)00375-6

Govender, 1999, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug, J. Controlled Release, 57, 171, 10.1016/S0168-3659(98)00116-3

Grislain, 1983, Pharmacokinetics and distribution of a biodegradable drug-carrier, Int. J. Pharm., 15, 335, 10.1016/0378-5173(83)90166-7

Guzman, 1996, Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty, Circulation, 94, 1441, 10.1161/01.CIR.94.6.1441

Ge, 2002, Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micelles, J. Pharm. Sci., 91, 1463, 10.1002/jps.10143

Herrero-Vanrell, 2005, Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release, J. Controlled Release, 102, 113, 10.1016/j.jconrel.2004.10.001

Jain, 2007, Use of nanoparticles for drug delivery in glioblastoma multiforme, Expert Rev. Neurother., 7, 363, 10.1586/14737175.7.4.363

Koo, 2006, Camptothecin in sterically stabilized phospholipid nano-micelles: a novel solvent pH change solubilization method, J. Nanosci. Nanotech., 6, 2996, 10.1166/jnn.2006.460

Kreuter, 1994, Nanoparticles, 165

Kreuter, 1994, Nanoparticles, 219

Kreuter, 2003, Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles, Pharma. Res., 20, 409, 10.1023/A:1022604120952

Kroll, 1998, Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood–brain and/or blood–tumor barriers, Neurosurgery, 43, 879, 10.1097/00006123-199810000-00090

Lamprecht, 2001, Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease, J. Pharmacol. Exp. Ther., 299, 775

Lee, 2006, A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas, Proc. Natl. Acad. Sci. U. S. A., 103, 16649, 10.1073/pnas.0607705103

Linhardt, 1989, Biodegradable polymers for controlled release of drugs, 53

Lockman, 2002, Nanoparticle technology for drug delivery across the blood–brain barrier, Drug Dev. Ind. Pharm., 28, 1, 10.1081/DDC-120001481

Lu, 2007, Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs, SMALL, 3, 1341, 10.1002/smll.200700005

MacDiarmid, 2007, Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics, Cancer Cell, 11, 431, 10.1016/j.ccr.2007.03.012

Maeda, 2001, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul., 41, 189, 10.1016/S0065-2571(00)00013-3

Magenheim, 1993, A new in vitro technique for the evaluation of drug release profile from colloidal carriers — ultrafiltration technique at low pressure, Int. J. Pharm., 94, 115, 10.1016/0378-5173(93)90015-8

McDevitt, 2007, Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes, J. Nucl. Med., 48, 1180, 10.2967/jnumed.106.039131

Moghimi, 2001, Long-circulating and target-specific nanoparticles: theory to practice, Pharmacol. Rev., 53, 283

Muller, 1996, Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407, J. Drug Target., 4, 161, 10.3109/10611869609015973

Olivier, 2005, Drug transport to brain with targeted nanoparticles, NeuroRx, 2, 108, 10.1602/neurorx.2.1.108

Panyam, 2003, Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles, J. Controlled Release, 92, 173, 10.1016/S0168-3659(03)00328-6

Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv. Drug Del. Rev., 55, 329, 10.1016/S0169-409X(02)00228-4

Panyam, 2003, Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles, Int. J. Pharm., 262, 1, 10.1016/S0378-5173(03)00295-3

Panyam, 2004, Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles, J. Pharm. Sci., 93, 1804, 10.1002/jps.20094

Peng, 2007, Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors, Prostate, 67, 855, 10.1002/pros.20576

Peracchia, 1997, PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics, J. Controlled Release, 46, 223, 10.1016/S0168-3659(96)01597-0

Pitt, 1981, Aliphatic polyesters II. The degradation of poly (dl-lactide), poly (epsilon-caprolactone), and their copolymers in vivo, Biomaterials, 2, 215, 10.1016/0142-9612(81)90060-0

Redhead, 2001, Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation, J. Controlled Release, 70, 353, 10.1016/S0168-3659(00)00367-9

Sahoo, 2002, Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity, Bioconjugate Chem., 13, 1031, 10.1021/bc020010k

Sutton, 2007, Functionalized micellar systems for cancer targeted drug delivery, Pharma. Res., 24, 1029, 10.1007/s11095-006-9223-y

Swarbrick, 2002

Tada, 2007, In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice, Cancer Res., 67, 1138, 10.1158/0008-5472.CAN-06-1185

van Vlerken, 2006, Multi-functional polymeric nanoparticles for tumour-targeted drug delivery, Expert Opin Drug Deliv., 3, 205, 10.1517/17425247.3.2.205

Vauthier, 2003, Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles, J. Controlled Release, 93, 151, 10.1016/j.jconrel.2003.08.005

Wagner, 2007, Programmed drug delivery: nanosystems for tumor targeting, Expert Opin. Bio. The., 7, 587, 10.1517/14712598.7.5.587

Woodward, 1985, The intracellular degradation of poly(epsilon-caprolactone), J. Biomed. Mater. Res., 19, 437, 10.1002/jbm.820190408

Zauner, 2001, In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density, J. Controlled Release, 71, 39, 10.1016/S0168-3659(00)00358-8